1-9 of 9
immune checkpoint inhibitors
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Risk Factors and Characteristics of Checkpoint Inhibitor–Associated Autoimmune Diabetes Mellitus (CIADM): A Systematic Review and Delineation From Type 1 Diabetes

Linda Wu, Venessa Tsang, Alexander M. Menzies, Sarah C. Sasson, Matteo S. Carlino, David A. Brown, Roderick Clifton-Bligh, Jenny E. Gunton
Journal: Diabetes Care
Diabetes Care 2023;46(6):1292–1299
DOI: https://doi.org/10.2337/dc22-2202
Published: 23 May 2023
View article titled, Risk Factors and Characteristics of Checkpoint Inhibitor–Associated Autoimmune Diabetes Mellitus (CIADM): A Systematic Review and Delineation From Type 1 Diabetes
Click here to open pdf in another window PDF for Risk Factors and Characteristics of Checkpoint Inhibitor–Associated Autoimmune Diabetes Mellitus (CIADM): A Systematic Review and Delineation From Type 1 Diabetes
Journal Articles

In This Issue of Diabetes Care

Max Bingham, PhD
Journal: Diabetes Care
Diabetes Care 2023;46(6):1110–1111
DOI: https://doi.org/10.2337/dc23-ti06
Published: 23 May 2023
View article titled, In This Issue of Diabetes Care
Click here to open pdf in another window PDF for In This Issue of Diabetes Care
Journal Articles

Immune Checkpoint Inhibitors and Risk of Type 1 Diabetes

Xuan Chen, Alison H. Affinati, Yungchun Lee, Adina F. Turcu, Norah Lynn Henry, Elena Schiopu, Angel Qin, Megan Othus, Dan Clauw, Nithya Ramnath, Lili Zhao
Journal: Diabetes Care
Diabetes Care 2022;45(5):1170–1176
DOI: https://doi.org/10.2337/dc21-2213
Published: 03 March 2022
View article titled, Immune Checkpoint Inhibitors and Risk of Type 1 Diabetes
Click here to open pdf in another window PDF for Immune Checkpoint Inhibitors and Risk of Type 1 Diabetes
Journal Articles

Reporting of Immune Checkpoint Inhibitor Therapy–Associated Diabetes, 2015–2019

Jiaqing Liu, Huaqiang Zhou, Yaxiong Zhang, Wenfeng Fang, Yunpeng Yang, Yan Huang, Li Zhang
Journal: Diabetes Care
Diabetes Care 2020;43(7):e79–e80
DOI: https://doi.org/10.2337/dc20-0459
Published: 11 May 2020
View article titled, Reporting of Immune Checkpoint Inhibitor Therapy–Associated Diabetes, 2015–2019
Click here to open pdf in another window PDF for Reporting of Immune Checkpoint Inhibitor Therapy–Associated Diabetes, 2015–2019
Journal Articles

Comment on Trinh et al. Successful Treatment of Immune Checkpoint Inhibitor–Induced Diabetes With Infliximab. Diabetes Care 2019;42:e153–e154

Anna Galligan, Balasubramanian Krishnamurthy, Thomas W. Kay
Journal: Diabetes Care
Diabetes Care 2020;43(1):e10
DOI: https://doi.org/10.2337/dc19-1747
Published: 12 December 2019
View article titled, Comment on Trinh et al. Successful Treatment of Immune Checkpoint Inhibitor–Induced Diabetes With Infliximab. Diabetes Care 2019;42:e153–e154
Click here to open pdf in another window PDF for Comment on Trinh et al. Successful Treatment of Immune Checkpoint Inhibitor–Induced Diabetes With Infliximab. Diabetes Care 2019;42:e153–e154
Journal Articles

Response to Comment on Trinh et al. Successful Treatment of Immune Checkpoint Inhibitor–Induced Diabetes With Infliximab. Diabetes Care 2019;42:e153–e154

Beckey Trinh, Marc Y. Donath, Heinz Läubli
Journal: Diabetes Care
Diabetes Care 2020;43(1):e11
DOI: https://doi.org/10.2337/dci19-0058
Published: 12 December 2019
View article titled, Response to Comment on Trinh et al. Successful Treatment of Immune Checkpoint Inhibitor–Induced Diabetes With Infliximab. Diabetes Care 2019;42:e153–e154
Click here to open pdf in another window PDF for Response to Comment on Trinh et al. Successful Treatment of Immune Checkpoint Inhibitor–Induced Diabetes With Infliximab. Diabetes Care 2019;42:e153–e154
Journal Articles

Successful Treatment of Immune Checkpoint Inhibitor–Induced Diabetes With Infliximab

Beckey Trinh, Marc Y. Donath, Heinz Läubli
Journal: Diabetes Care
Diabetes Care 2019;42(9):e153–e154
DOI: https://doi.org/10.2337/dc19-0908
Published: 15 July 2019
View article titled, Successful Treatment of Immune Checkpoint Inhibitor–Induced Diabetes With Infliximab
Click here to open pdf in another window PDF for Successful Treatment of Immune Checkpoint Inhibitor–Induced Diabetes With Infliximab
Journal Articles

Comment on Wright et al. Increased Reporting of Immune Checkpoint Inhibitor–Associated Diabetes. Diabetes Care 2018;41:e150–e151

Line Bisgaard Jørgensen, Knud Yderstræde
Journal: Diabetes Care
Diabetes Care 2019;42(5):e77
DOI: https://doi.org/10.2337/dc18-2595
Published: 15 April 2019
View article titled, Comment on Wright et al. Increased Reporting of Immune Checkpoint Inhibitor–Associated Diabetes. Diabetes Care 2018;41:e150–e151
Click here to open pdf in another window PDF for Comment on Wright et al. Increased Reporting of Immune Checkpoint Inhibitor–Associated Diabetes. Diabetes Care 2018;41:e150–e151
Journal Articles

Increased Reporting of Immune Checkpoint Inhibitor–Associated Diabetes

Jordan J. Wright, Joe-Elie Salem, Douglas B. Johnson, Bénédicte Lebrun-Vignes, Angeliki Stamatouli, James W. Thomas, Kevan C. Herold, Javid Moslehi, Alvin C. Powers
Journal: Diabetes Care
Diabetes Care 2018;41(12):e150–e151
DOI: https://doi.org/10.2337/dc18-1465
Published: 10 October 2018
View article titled, Increased Reporting of Immune Checkpoint Inhibitor–Associated Diabetes
Click here to open pdf in another window PDF for Increased Reporting of Immune Checkpoint Inhibitor–Associated Diabetes